Herpes simplex virus infection in pregnancy: Clinical sciences

Last updated: January 30, 2025

Herpes simplex virus infection in pregnancy: Clinical sciences

Pregnancy, childbirth, and the puerperium

Pregnancy, childbirth, and the puerperium

Preconception care: Clinical sciences
Antepartum fetal surveillance: Clinical sciences
Fetal aneuploidy screening: Clinical sciences
Maternal D alloimmunization (prevention): Clinical sciences
Antepartum care (first trimester): Clinical sciences
Antepartum care (second trimester): Clinical sciences
Antepartum care (third trimester): Clinical sciences
Cytomegalovirus (CMV), parvovirus B19, varicella zoster, and toxoplasmosis infection in pregnancy: Clinical sciences
Group B streptococcus (GBS) colonization in pregnancy: Clinical sciences
Herpes simplex virus infection in pregnancy: Clinical sciences
Abdominal trauma in pregnancy: Clinical sciences
Anemia in pregnancy: Clinical sciences
Approach to acute pelvic pain (GYN): Clinical sciences
Approach to diabetes in pregnancy: Clinical sciences
Approach to first trimester bleeding: Clinical sciences
Approach to hypertensive disorders in pregnancy: Clinical sciences
Approach to third trimester bleeding: Clinical sciences
Cholestasis of pregnancy: Clinical sciences
Diabetes in pregnancy (GDM, T1DM, and T2DM): Clinical sciences
Early pregnancy loss: Clinical sciences
Ectopic pregnancy: Clinical sciences
Fetal growth restriction: Clinical sciences
Gestational hypertension, preeclampsia, eclampsia, and HELLP: Clinical sciences
Hemoglobinopathies in pregnancy: Clinical sciences
Intraamniotic infection: Clinical sciences
Maternal D alloimmunization (management): Clinical sciences
Multifetal gestation: Clinical sciences
Nausea and vomiting of pregnancy: Clinical sciences
Placenta accreta spectrum: Clinical sciences
Placenta previa and vasa previa: Clinical sciences
Placental abruption: Clinical sciences
Therapeutic and induced abortions: Clinical sciences
Induction of labor: Clinical sciences
Intrapartum care (1st, 2nd, 3rd, and 4th stages): Clinical sciences
Intrapartum fetal heart rate monitoring: Clinical sciences
Late-term and postterm pregnancy: Clinical sciences
Pain management during labor: Clinical sciences
Prelabor rupture of membranes: Clinical sciences
Preterm labor: Clinical sciences
Protraction and arrest disorders: Clinical sciences
Shoulder dystocia: Clinical sciences
Vaginal birth after cesarean (VBAC): Clinical sciences
Approach to postpartum fever: Clinical sciences
Approach to postpartum hemorrhage: Clinical sciences
Perinatal depression and anxiety: Clinical sciences
Uterine atony: Clinical sciences
Immediate care of the well newborn: Clinical sciences
Approach to a rash in the well newborn and infant: Clinical sciences
Approach to anemia in the newborn and infant (destruction and blood loss): Clinical sciences
Approach to anemia in the newborn and infant (underproduction): Clinical sciences
Approach to birth injury (pediatrics): Clinical sciences
Approach to complications of prematurity (early): Clinical sciences
Approach to complications of prematurity (late): Clinical sciences
Approach to congenital infections: Clinical sciences
Approach to cyanosis (newborn): Clinical sciences
Approach to hypotonia (newborn and infant): Clinical sciences
Approach to jaundice (newborn and infant): Clinical sciences
Approach to respiratory distress (newborn): Clinical sciences
Approach to vomiting (newborn and infant): Clinical sciences
Neonatal respiratory distress syndrome: Clinical sciences
Alcohol, tobacco, cannabinoid, and substance use in pregnancy: Clinical sciences
Approach to prenatal teratogen exposure: Clinical sciences
Asthma in pregnancy: Clinical sciences
Chronic hypertension in pregnancy: Clinical sciences
Urinary tract infections and kidney stones in pregnancy: Clinical sciences
Venous thromboembolism in pregnancy: Clinical sciences
Anatomy clinical correlates: Female pelvis and perineum
Chlamydia trachomatis
Neisseria gonorrhoeae
Streptococcus agalactiae (Group B Strep)
Treponema pallidum (Syphilis)
Toxoplasma gondii (Toxoplasmosis)
Cytomegalovirus
Hepatitis B and Hepatitis D virus
Herpes simplex virus
HIV (AIDS)
Influenza virus
Parvovirus B19
Rubella virus
Varicella zoster virus
Congenital TORCH infections: Pathology review
Complications during pregnancy: Pathology review
Estrogens and antiestrogens
Progestins and antiprogestins
Uterine stimulants and relaxants

Decision-Making Tree

Transcript

Watch video only

Herpes simplex virus, or HSV infection is a common sexually transmitted infection or STI. There are two types of this virus: HSV1 and 2. Even though HSV1 is associated with cold sores, and HSV2 with genital ulcers, both can cause genital ulcers so presentation alone is not enough to differentiate between the two. Determining the HSV subtype is important as it can provide information on the risk of recurrence.

Now, the infection itself carries some risks. A primary outbreak in the first trimester of pregnancy can result in neonatal chorioretinitis, microcephaly, and skin lesions, while a primary outbreak near the time of delivery significantly increases the risk for neonatal transmission.

Recurrent infections can also be transmitted to the neonate during delivery through intrapartum exposure to the virus in the maternal genital tract and can result in disseminated disease or CNS disease, with the possibility for long-term neurologic impact.

When a patient presents with a chief concern suggesting HSV infection in pregnancy, start with a focused history and physical examination.

History might reveal a prior HSV outbreak. Additionally, the patient might have a prior documented history of positive HSV antibodies. They might report single or multiple genital lesions, which are possibly painful. A primary outbreak typically involves multiple painful lesions, whereas a recurrent outbreak more commonly presents as a single ulcer that is mildly painful or non-painful. Be sure to ask about prodromal symptoms that occur with recurrent infections including burning or tingling in the area where the outbreak normally occurs.

Lastly, patients might report vulvar pruritus, dysuria, or systemic symptoms such as fever, headache, or malaise.

When it comes to the physical exam, the focus is on the genital area. You might find perineal erythema and genital ulcers. Ulcers could be single and unilateral or multiple and bilateral. Additionally, the exam might reveal tender inguinal lymphadenopathy if there is a primary infection.

Now, if the patient can tolerate it, perform a speculum exam to evaluate for cervical lesions and consider testing for concurrent sexually transmitted infections and/or vaginitis if clinically indicated.

Here’s a high-yield fact! HSV is typically transmitted through direct contact and has an incubation period of 2-12 days.

Alright, if the patient has a prior history of genital herpes, we are talking about a recurrent infection.

The current outbreak is treated with antiviral medication, such as acyclovir or valacyclovir. Additionally, all pregnant individuals with a history of HSV require suppressive therapy with antivirals beginning at 36 0/7 weeks gestation through delivery. Suppressive therapy not only reduces the risk of an outbreak at the time of delivery but also decreases asymptomatic shedding, reducing the risk of acquired intrapartum neonatal herpes.

Finally, any patient who presents in labor with a history of HSV requires assessment for both prodromal symptoms and any active genital lesions, as these are contraindications to a vaginal delivery. A thorough perineal, sterile speculum and visual cervical examination must be performed to assess for genital ulcers or lesions. If there are no prodromal symptoms or lesions, the patient can continue laboring and undergo a vaginal delivery. However, if prodromal symptoms or an active lesion are present, a C-section is recommended to decrease the risk of neonatal herpes.

After delivery, notify the pediatrics team of the patient’s HSV status, so that they can properly examine the neonate for symptoms of neonatal transmission. Okay, let’s go back and talk about patients with no prior history of genital herpes.

Your next step here is to order a direct viral test on the lesion, which involves unroofing a lesion with a swab and sending collected fluid for viral culture and/or PCR-based HSV antigen detection. Additionally, obtain a type-specific serologic test to check for HSV1 and/or HSV2 antibodies. Keep in mind that If a patient reports a recent history of genital ulcers or lesions but does not currently have one, or has a clinical history that otherwise might suggest HSV, serology alone is enough.

Sources

  1. "Management of Genital Herpes in Pregnancy: ACOG Practice Bulletin Summary, Number 220. " Obstet Gynecol (2020;135(5):1236-1238.)
  2. "Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection." Cochrane Database Syst Rev. (2008;(1):CD004946. Published 2008 Jan 23. )
  3. "Maternal and neonatal herpes simplex virus infections. " Am J Perinatol. (2013;30(2):113-119.)
  4. "Herpes simplex virus and pregnancy: a review of the management of antenatal and peripartum herpes infections. " Obstet Gynecol Surv. (2011;66(10):629-638.)